Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vitro</i> models of oxidative stress, mitochondrial dysfunction, and inflammation for evaluation of neuroprotective biomaterials.

Journal of materials chemistry. B·2026
Same author

Designed Liquid Crystalline Nanoassemblies From Clinically Validated Polyunsaturated Lipids for Combined Antioxidant, Anti-Apoptotic, and Neurotrophic Treatments.

Advanced healthcare materials·2026
Same author

Gut Microbiota Affects Age-Related Plasma Metabolites.

Microorganisms·2026
Same author

Sub-Arctic bacterioplankton in-situ response to crude oil and identification of the oil-degrading community by DNA-SIP and cultivation.

Marine pollution bulletin·2026
Same author

Allogeneic hematopoietic cell transplantation for partial RAG deficiency in children and adults: Excellent outcomes with a reduced-intensity posttransplantation cyclophosphamide-based approach.

The Journal of allergy and clinical immunology·2026
Same author

Corrections to "Dynamic Self-Assembly and Stimuli-Responsive Disassembly of Bioactive-Loaded Cubosomes in Biomimetic Media Traced by Real-Time Small-Angle X-ray Scattering and Cryogenic Transmission Electron Microscopy".

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: May 9, 2026

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Neurotrophin delivery using nanotechnology.

Angelina Angelova1, Borislav Angelov, Markus Drechsler

  • 1CNRS UMR8612 Institut Galien Paris-Sud, 5 rue J.B. Clément, F-92296 Châtenay-Malabry cedex, France; University Paris Sud 11, Faculté de Pharmacie, LabEx LERMIT, Châtenay-Malabry, France.

Drug Discovery Today
|July 30, 2013
PubMed
Summary

Targeted nanoparticle delivery of neurotrophins can treat neurodegenerative diseases and psychiatric disorders by enhancing neuronal survival and function. This approach aims for localized brain delivery, minimizing systemic exposure for improved clinical outcomes.

More Related Videos

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Area of Science:

  • Neuroscience
  • Biotechnology
  • Pharmacology

Background:

  • Neurotrophins are crucial for neuronal survival, plasticity, and function in both central (CNS) and peripheral nervous systems.
  • Deficits or overexpression of neurotrophins are implicated in neurodegenerative diseases and psychiatric disorders.
  • Current therapeutic strategies focus on controlled neurotrophin dosage in the brain.

Purpose of the Study:

  • To propose nanoparticulate carriers for targeted neurotrophin delivery within specific brain regions.
  • To minimize systemic biodistribution of neurotrophin delivery systems.
  • To advance clinical benefits for neuroregeneration and treatment of neurological disorders.

Main Methods:

  • Development of targeted nanoparticulate delivery systems.
  • Focus on localized delivery within the CNS.
  • Minimization of off-target effects in the systemic circulation.

Main Results:

  • Demonstration of improved targeted neurotrophin delivery to localized CNS areas.
  • Potential for enhanced therapeutic efficacy through precise delivery.
  • Reduced systemic exposure compared to conventional methods.

Conclusions:

  • Nanoparticulate carriers offer a promising strategy for targeted neurotrophin delivery in the brain.
  • This approach holds potential for treating neurodegenerative and psychiatric disorders.
  • Further development is warranted for clinical translation and neuroregeneration.